Cocrystal Pharma, Inc. (18) | Business Finance (11)

Browse by Subcategory

Equity Distribution Agreements (3 contracts)
Purchase Agreements (4)
Stock Agreements (1)
Underwriting Agreements (3)

Recent Contracts

Underwriting Agreement, dated as of May 4, 2021 by and between Cocrystal Pharma, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on May 5, 2021)
Description of Capital Stock (Filed With SEC on March 27, 2020)
Form of Securities Purchase Agreement, dated March 9, 2020, by and between the Company and the Purchasers (Filed With SEC on March 13, 2020)
Amendment to the Amended and Restated Equity Distribution Agreement, dated October 2, 2019 (Filed With SEC on January 29, 2020)
Amended and Restated Underwriting Agreement, dated as of August 26, 2020, by and between Cocrystal Pharma, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on August 27, 2020)
Form of Securities Purchase Agreement, dated February 27, 2020, by and between the Company and the Purchasers (Filed With SEC on March 4, 2020)
Form of Securities Purchase Agreement (Filed With SEC on January 31, 2020)
Underwriting Agreement, dated as of October 30, 2019, by and between Cocrystal Pharma, Inc. and Aegis Capital Corp (Filed With SEC on October 31, 2019)
Amended and Restated Equity Distribution Agreement, dated October 30, 2019 (Filed With SEC on October 30, 2019)
Amendment to Equity Distribution Agreement, dated March 20, 2019 (Filed With SEC on March 26, 2019)
Securities Purchase Agreement, dated March 11, 2019 (Filed With SEC on March 11, 2019)